Inside the research
AdaptHealth Corp.
AHCO Research profile · latest available data
Price overview
$5.64
▲ +0.07 (+1.3%)
| 52w hi | $13.38 |
|---|---|
| 52w lo | $5.22 |
| Vol | 1.35M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.46
| Short | -0.43 |
|---|---|
| Medium | -0.42 |
| Long | -0.61 |
computed 2026-09-27
Key fundamentals
AdaptHealth Corp.
Healthcare · Medical Devices
| Market cap | $752.43M |
|---|---|
| Enterprise value | $2.78B |
| Forward P/E | -45.48x |
| EV / EBITDA | 4.77x |
| P / S (ttm) | 0.23x |
| Profit margin | -6.8% |
| Return on equity | -15.2% |
| Revenue growth | +12.7% |
| Debt / equity | 148.97 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.05 | |
| Sector | +0.08 | |
| Technical | -0.36 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.
Risk Metrics
| Beta vs SPX | 0.65 |
|---|---|
| Corr SPX | 0.18 |
| Annual vol | 57.8% |
| Annual ret | -16.8% |
| Sharpe | -0.29 |
| Max DD | -61.0% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $14.00 |
|---|---|
| High / Low | $18.00 / $11.00 |
| Median | $14.00 |
| Analysts | 8 |
| Strong Buy | 1 | |
|---|---|---|
| Buy | 5 | |
| Hold | 2 | |
| Sell | 0 | |
| Strong Sell | 0 |
Recent rating actions
| 2026-05-06 | UBS | → Buy |
| 2026-05-06 | Canaccord Genuity | → Buy |
| 2026-04-13 | Truist Securities | → Buy |
| 2026-02-26 | Leerink Partners | → Outperform |
| 2025-11-06 | Canaccord Genuity | → Buy |
| 2025-05-12 | Truist Securities | → Buy |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-04 | Earnings Release, Exhibits | read |
| 2026-07-20 | Material Agreement, Exhibits | read |
| 2026-07-07 | Reg FD Disclosure | read |
| 2026-07-02 | 1.05 | read |
| 2026-06-22 | Shareholder Vote | read |
| 2026-05-05 | Earnings Release, Officer / Director Change… | read |
| 2026-04-13 | Material Agreement, Termination of Agreement… | read |
| 2026-02-24 | Earnings Release, Exhibits | read |
| 2025-11-04 | Earnings Release, Exhibits | read |
| 2025-08-05 | Earnings Release, Exhibits | read |
| 2025-08-05 | Reg FD Disclosure, Exhibits | read |
| 2025-06-30 | Reg FD Disclosure, Exhibits | read |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 8 |
| Top-5 share | 95.8% |
| HHI | 3,633 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| Fidelity / FMR LLC | $82.14M | 7.88M |
| State Street Corp | $48.24M | 4.63M |
| Renaissance Technologies | $7.96M | 764.34K |
| AQR Capital Management | $7.94M | 761.86K |
| Citadel Advisors | $6.70M | 643.25K |
| Millennium Management | $3.63M | 347.92K |
| Capital Research / Capital World | $3.10M | 297.04K |
| T. Rowe Price Group | $1.32K | 127.04K |
As of 2026-06-30
SEC Filings
The Long Run
FY 2018–2025 · 8 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $3.26B | +35.4% | |
| Operating income | $90.87M | +19.6% | |
| Net income | -$678.89M | +198.0% | |
| Cash from ops | $480.67M | +38.4% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $5.58 | $5.66 | $5.52 | $5.64 | 1.35M |
| Sep 24 | $5.65 | $5.76 | $5.56 | $5.57 | 2.10M |
| Sep 23 | $5.77 | $5.81 | $5.64 | $5.70 | 1.99M |
| Sep 22 | $5.79 | $5.89 | $5.72 | $5.77 | 2.76M |
| Sep 21 | $5.74 | $5.89 | $5.59 | $5.75 | 2.78M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →